{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:08:56Z","timestamp":1728360536888},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,7]]},"DOI":"10.7759\/cureus.70972","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T07:47:36Z","timestamp":1728287256000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperviscosity Syndrome in Immunoglobulin G4 (IgG4)-Related Disease and the Use of Therapeutic Plasma Exchange: A Case Report"],"prefix":"10.7759","author":[{"given":"Lennart","family":"Marahrens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhys","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamir","family":"Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"11","author":"Kamisawa T","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015, 11:1460-71. 10.1016\/S0140-6736(14)60720-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03080190030008","article-title":"Serum hyperviscosity syndrome","volume":"192","author":"Fahey JL","year":"1965","unstructured":"Fahey JL, Barth WF, Solomon A. Serum hyperviscosity syndrome. JAMA. 1965, 192:464-7. 10.1001\/jama.1965.03080190030008","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994921","article-title":"The hyperviscosity syndromes","volume":"25","author":"Kwaan HC","year":"1999","unstructured":"Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost. 1999, 25:199-208. 10.1055\/s-2007-994921","journal-title":"Semin Thromb Hemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta J","year":"2003","unstructured":"Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost. 2003, 29:467-71. 10.1055\/s-2003-44554","journal-title":"Semin Thromb Hemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly\u2010Smith L","year":"2023","unstructured":"Connelly\u2010Smith L, Alquist CR, Aqui NA, et al.. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher. 2023, 38:77-278. 10.1002\/jca.22043","journal-title":"J Clin Apher"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00056-9","article-title":"Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management","volume":"8","author":"Zhao EJ","year":"2021","unstructured":"Zhao EJ, Cheng CV, Mattman A, Chen LY. Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management. Lancet Haematol. 2021, 8:e365-75. 10.1016\/S2352-3026(21)00056-9","journal-title":"Lancet Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.026","article-title":"Waldenstr\u00f6m's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia","volume":"9","author":"Stone MJ","year":"2009","unstructured":"Stone MJ. Waldenstr\u00f6m's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia. Clin Lymphoma Myeloma. 2009, 9:97-9. 10.3816\/CLM.2009.n.026","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.10.017","article-title":"Therapeutic plasma exchange: core curriculum 2023","volume":"81","author":"Cervantes CE","year":"2023","unstructured":"Cervantes CE, Bloch EM, Sperati CJ. Therapeutic plasma exchange: core curriculum 2023. Am J Kidney Dis. 2023, 81:475-92. 10.1053\/j.ajkd.2022.10.017","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace ZS","year":"2023","unstructured":"Wallace ZS, Miles G, Smolkina E, et al.. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis. 2023, 82:957-62. 10.1136\/ard-2023-223950","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283418057","article-title":"A clinical overview of IgG4-related systemic disease","volume":"23","author":"Khosroshahi A","year":"2011","unstructured":"Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011, 23:57-66. 10.1097\/BOR.0b013e3283418057","journal-title":"Curr Opin Rheumatol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo P","year":"2000","unstructured":"Angulo P, Batts KP, Jorgensen RA, LaRusso NA, Lindor KD. Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol. 2000, 95:2333-7.","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201610001-01313","article-title":"Dramatic effect of rituximab in immunoglobulin g4-related primary sclerosing cholangitis","volume":"111","author":"Manickavasagan HR","year":"2016","unstructured":"Manickavasagan HR, Wood R, Kindsfather S, Munoz SJ. Dramatic effect of rituximab in immunoglobulin g4-related primary sclerosing cholangitis. Am J Gastroenterol. 2016, 111:S586-7.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers MN","year":"2015","unstructured":"Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015, 74:14-8. 10.1136\/annrheumdis-2013-204907","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease","volume":"22","author":"Sato Y","year":"2009","unstructured":"Sato Y, Kojima M, Takata K, et al.. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009, 22:589-99. 10.1038\/modpathol.2009.17","journal-title":"Mod Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30017-7","article-title":"Management of IgG4-related disease","volume":"1","author":"Zhang W","year":"2019","unstructured":"Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheumatol. 2019, 1:e55-65. 10.1016\/S2665-9913(19)30017-7","journal-title":"Lancet Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12059","article-title":"IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy","volume":"90","author":"Wong PC","year":"2013","unstructured":"Wong PC, Fung AT, Gerrie AS, et al.. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol. 2013, 90:250-6. 10.1111\/ejh.12059","journal-title":"Eur J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21584","article-title":"A young woman with episodic angioedema, papilledema, and eosinophilia","volume":"85","author":"Chen LY","year":"2010","unstructured":"Chen LY, Lai EJ, Collins DR, Ostrow DN, Sreenivasan GM. A young woman with episodic angioedema, papilledema, and eosinophilia. Am J Hematol. 2010, 85:124-7. 10.1002\/ajh.21584","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.201","article-title":"Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions","volume":"3","author":"Chen LY","year":"2015","unstructured":"Chen LY, Wong PC, Noda S, Collins DR, Sreenivasan GM, Coupland RC. Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions. Clin Case Rep. 2015, 3:217-26. 10.1002\/ccr3.201","journal-title":"Clin Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Brito-Zer\u00f3n P","year":"2014","unstructured":"Brito-Zer\u00f3n P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014, 13:1203-10. 10.1016\/j.autrev.2014.08.013","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/303705-hyperviscosity-syndrome-in-immunoglobulin-g4-igg4-related-disease-and-the-use-of-therapeutic-plasma-exchange-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T07:47:40Z","timestamp":1728287260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/303705-hyperviscosity-syndrome-in-immunoglobulin-g4-igg4-related-disease-and-the-use-of-therapeutic-plasma-exchange-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.70972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,7]]}}}